Sung‐Shuo Kao

638 total citations
29 papers, 504 citations indexed

About

Sung‐Shuo Kao is a scholar working on Surgery, Gastroenterology and Small Animals. According to data from OpenAlex, Sung‐Shuo Kao has authored 29 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 13 papers in Gastroenterology and 9 papers in Small Animals. Recurrent topics in Sung‐Shuo Kao's work include Helicobacter pylori-related gastroenterology studies (16 papers), Gastroesophageal reflux and treatments (11 papers) and Veterinary medicine and infectious diseases (9 papers). Sung‐Shuo Kao is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (16 papers), Gastroesophageal reflux and treatments (11 papers) and Veterinary medicine and infectious diseases (9 papers). Sung‐Shuo Kao collaborates with scholars based in Taiwan and United States. Sung‐Shuo Kao's co-authors include Ping‐I Hsu, Feng‐Woei Tsay, Deng‐Chyang Wu, Nan‐Jing Peng, Kuo‐Wang Tsai, Wen‐Chi Chen, Tzung‐Jiun Tsai, Hsien‐Chung Yu, Kwok‐Hung Lai and Huay-Min Wang and has published in prestigious journals such as PLoS ONE, Hepatology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Sung‐Shuo Kao

28 papers receiving 495 citations

Peers

Countries citing papers authored by Sung‐Shuo Kao

Since Specialization

Citations

This map shows the geographic impact of Sung‐Shuo Kao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung‐Shuo Kao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung‐Shuo Kao more than expected).

Fields of papers citing papers by Sung‐Shuo Kao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung‐Shuo Kao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung‐Shuo Kao. The network helps show where Sung‐Shuo Kao may publish in the future.

Co-authorship network of co-authors of Sung‐Shuo Kao

This figure shows the co-authorship network connecting the top 25 collaborators of Sung‐Shuo Kao. A scholar is included among the top collaborators of Sung‐Shuo Kao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung‐Shuo Kao. Sung‐Shuo Kao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sequential changes of antibiotic resistances of Helicobacter pylori in Taiwan from 2019 to 2024 2025 ·World Journal of Gastroenterology ·(unknown), Feng‐Woei Tsay, Deng-Chyang Wu, Jyh‐Chin Yang, Seng‐Kee Chuah, Kuan-Yang Chen, Chien‐Lin Chen, Chia-Long Lee, (unknown), (unknown), (unknown), Wei‐Chen Tai, Chao‐Hung Kuo, Wei‐Yi Lei, Sung‐Shuo Kao, (unknown), (unknown), (unknown), Ping‐I Hsu, Ming‐Jen Sheu	0
2	Risk factors for symptom relapse in patients with Los Angeles Grade A/B erosive esophagitis 2023 ·Advances in digestive medicine ·(unknown), Seng‐Kee Chuah, Ping‐I Hsu, Ching‐Liang Lu, Sung‐Shuo Kao, Wei‐Chen Tai, (unknown), (unknown), Wenwei Huang, (unknown), (unknown), (unknown), Chao‐Hung Kuo, Deng‐Chyang Wu	1
3	Propranolol use in patients with cirrhosis and refractory ascites 2022 ·Saudi Journal of Gastroenterology ·(unknown), Yun‐Da Li, (unknown), Wei-Chun Huang, Sung‐Shuo Kao, (unknown)	4
4	Hepatitis B Virus Screening Before Cancer Chemotherapy in Taiwan: A Nationwide Population-Based Study 2021 ·Frontiers in Medicine ·Wei‐Chih Sun, Pei‐Ling Tang, Wen‐Chi Chen, Feng‐Woei Tsay, Huay-Min Wang, Tzung‐Jiun Tsai, Sung‐Shuo Kao, Jin‐Shiung Cheng, Wei‐Lun Tsai	2
5	Tetracycline‐levofloxacin versus amoxicillin‐levofloxacin quadruple therapies in the second‐line treatment of Helicobacter pylori infection 2021 ·Helicobacter ·Ping‐I Hsu, Feng‐Woei Tsay, John Y. Kao, Nan‐Jing Peng, Yanhua Chen, (unknown), Chao‐Hung Kuo, Sung‐Shuo Kao, Huay‐Min Wang, (unknown), (unknown), Seng‐Kee Chuah, Deng‐Chyang Wu	11
6	Equivalent efficacies of reverse hybrid and concomitant therapies in first‐line treatment of Helicobacter pylori infection 2020 ·Journal of Gastroenterology and Hepatology ·Ping‐I Hsu, Feng‐Woei Tsay, John Y. Kao, Nan‐Jing Peng, Kuo‐Wang Tsai, Tzung‐Jiun Tsai, Chao‐Hung Kuo, Sung‐Shuo Kao, Huay‐Min Wang, Yanhua Chen, (unknown), Deng‐Chyang Wu	22
7	Short‐term and long‐term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota 2019 ·Journal of Gastroenterology and Hepatology ·Ping‐I Hsu, Chao‐Yu Pan, John Y. Kao, Feng‐Woei Tsay, Nan‐Jing Peng, Sung‐Shuo Kao, Yanhua Chen, Tzung‐Jiun Tsai, Deng‐Chyang Wu, Kuo‐Wang Tsai	39
8	Gallbladder function predicts subsequent biliary complications in patients with common bile duct stones after endoscopic treatment? 2018 ·BMC Gastroenterology ·Tzung‐Jiun Tsai, Hoi‐Hung Chan, Kwok‐Hung Lai, (unknown), Sung‐Shuo Kao, Wei‐Chih Sun, E‐Ming Wang, Wei‐Lun Tsai, Kung‐Hung Lin, Hsien‐Chung Yu, Wen‐Chi Chen, Huay-Min Wang, Feng‐Woei Tsay, Huey‐Shyan Lin, Jin‐Shiung Cheng, Ping‐I Hsu	15
9	Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial 2018 ·Clinical Gastroenterology and Hepatology ·Ping‐I Hsu, Feng‐Woei Tsay, David Y. Graham, Tzung‐Jiun Tsai, Kuo‐Wang Tsai, John Y. Kao, Nan‐Jing Peng, Chao‐Hung Kuo, Sung‐Shuo Kao, Huay-Min Wang, (unknown), Deng‐Chyang Wu	34
10	Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria 2018 ·Helicobacter ·Ping‐I Hsu, Chao‐Yu Pan, John Y. Kao, Feng‐Woei Tsay, Nan‐Jing Peng, Sung‐Shuo Kao, Huay‐Min Wang, Tzung‐Jiun Tsai, Deng‐Chyang Wu, Chien‐Lin Chen, Kuo‐Wang Tsai, (unknown)	78
11	Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial 2017 ·The American Journal of Gastroenterology ·Ping‐I Hsu, (unknown), Sung‐Shuo Kao, Wen‐Hung Hsu, Jin‐Shiung Cheng, Nan‐Jing Peng, Kuo‐Wang Tsai, Huang‐Ming Hu, Yao‐Kuang Wang, Seng‐Kee Chuah, (unknown), Deng‐Chyang Wu	32
12	A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance 2017 ·Antimicrobial Agents and Chemotherapy ·Feng‐Woei Tsay, Deng‐Chyang Wu, Hsien‐Chung Yu, Sung‐Shuo Kao, Kung‐Hung Lin, Jin‐Shiung Cheng, Huay-Min Wang, Wen‐Chi Chen, Wei‐Chih Sun, Kuo‐Wang Tsai, Ping‐I Hsu	27
13	Is endoscopic treatment beneficial in patients with clinically suspicious of common bile duct stones but no obvious filling defects during the ERCP examination? 2016 ·BMC Gastroenterology ·(unknown), Kwok‐Hung Lai, Tzung‐Jiun Tsai, Kung‐Hung Lin, Kaiming Wang, Sung‐Shuo Kao, Wei‐Chih Sun, Jin‐Shiung Cheng, Ping‐I Hsu, Wei‐Lun Tsai, Wen‐Chi Chen, Yun‐Da Li, E‐Ming Wang, Huey‐Shyan Lin, Hoi‐Hung Chan	3
14	Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan 2016 ·PLoS ONE ·(unknown), Sung‐Shuo Kao, Ren‐Hua Chung	18
15	Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial 2016 ·The American Journal of Gastroenterology ·Ping‐I Hsu, Deng‐Chyang Wu, Feng‐Woei Tsay, Jin‐Shiung Cheng, Chun‐Peng Liu, Kwok‐Hung Lai, Wen‐Chi Chen, Huay-Min Wang, Tzung‐Jiun Tsai, Kuo‐Wang Tsai, Sung‐Shuo Kao	3
16	A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection 2015 ·Medicine ·Ping‐I Hsu, Sung‐Shuo Kao, Deng‐Chyang Wu, Wen‐Chi Chen, Nan‐Jing Peng, Hsien‐Chung Yu, Huay-Min Wang, Kwok‐Hung Lai, Jin‐Shiung Cheng, (unknown), Seng‐Kee Chuah, Feng‐Woei Tsay	26
17	Improvement of Short-Term Outcomes for High-Risk Bleeding Peptic Ulcers With Addition of Argon Plasma Coagulation Following Endoscopic Injection Therapy 2015 ·Medicine ·Huay-Min Wang, Wei‐Lun Tsai, Hsien‐Chung Yu, Hoi‐Hung Chan, Wen‐Chi Chen, Kung‐Hung Lin, Tzung‐Jiun Tsai, Sung‐Shuo Kao, Wei‐Chih Sun, Ping‐I Hsu	8
18	The Efficacy of Endoscopic Papillary Balloon Dilation for Patients with Acute Biliary Pancreatitis 2015 ·Gastroenterology Research and Practice ·Wei‐Chih Sun, Hoi‐Hung Chan, Kwok‐Hung Lai, Tzung‐Jiun Tsai, Huey‐Shyan Lin, Kung‐Hung Lin, Kaiming Wang, Sung‐Shuo Kao, (unknown), Jin‐Shiung Cheng, Ping‐I Hsu, Wei‐Lun Tsai, Wen‐Chi Chen, Yun‐Da Li, E‐Ming Wang	2
19	Impact of Blood Type, Functional Polymorphism (T-1676C) of theCOX-1Gene Promoter and Clinical Factors on the Development of Peptic Ulcer during Cardiovascular Prophylaxis with Low-Dose Aspirin 2014 ·BioMed Research International ·(unknown), (unknown), Angela Chen, Feng‐Woei Tsay, Kwok‐Hung Lai, Sung‐Shuo Kao, Wen‐Chi Chen, Chao‐Hung Kuo, Nan‐Jing Peng, Hui‐Hwa Tseng, Ping‐I Hsu	4
20	7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate forHelicobacter pyloriin Taiwan 2012 ·Gastroenterology Research and Practice ·Sung‐Shuo Kao, Wen‐Chi Chen, Ping‐I Hsu, Kwok‐Hung Lai, Hsien‐Chung Yu, (unknown), Nan‐Jing Peng, Chiun‐Ku Lin, Hoi‐Hung Chan, Wei‐Lun Tsai, Huay-Min Wang, Tzung‐Jiun Tsai, Kung‐Hung Lin, Feng‐Woei Tsay	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact